208 related articles for article (PubMed ID: 27718310)
21. A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial.
Pace D; Snape M; Westcar S; Oluwalana C; Yu LM; Begg N; Wysocki J; Czajka H; Maechler G; Boutriau D; Pollard AJ
Arch Dis Child; 2008 Nov; 93(11):963-70. PubMed ID: 18463125
[TBL] [Abstract][Full Text] [Related]
22. Revaccination of children after completion of standard chemotherapy for acute lymphoblastic leukaemia: a pilot study comparing different schedules.
Lehrnbecher T; Schubert R; Allwinn R; Dogan K; Koehl U; Grüttner HP
Br J Haematol; 2011 Mar; 152(6):754-7. PubMed ID: 21250973
[TBL] [Abstract][Full Text] [Related]
23. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.
Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C
P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673
[TBL] [Abstract][Full Text] [Related]
24. Revaccination of children with acute lymphoblastic leukemia following completion of chemotherapy.
Anafy A; Gilad G; Michaan N; Elhasid R; Rosenfeld-Kaidar H; Arad-Cohen N; Cohen MS; Shachor-Meyouhas Y; Grisaru-Soen G
Pediatr Blood Cancer; 2023 Jun; 70(6):e30321. PubMed ID: 37036274
[TBL] [Abstract][Full Text] [Related]
25. Measles, mumps, and rubella antibody status and response to immunization in children after therapy for acute lymphoblastic leukemia.
Aytac S; Yalcin SS; Cetin M; Yetgin S; Gumruk F; Tuncer M; Yurdakok K; Gurgey A
Pediatr Hematol Oncol; 2010 Aug; 27(5):333-43. PubMed ID: 20469978
[TBL] [Abstract][Full Text] [Related]
26. Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic Malignancies.
Shah GL; Shune L; Purtill D; Devlin S; Lauer E; Lubin M; Bhatt V; McElrath C; Kernan NA; Scaradavou A; Giralt S; Perales MA; Ponce DM; Young JW; Shah M; Papanicolaou G; Barker JN
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2160-2166. PubMed ID: 26271191
[TBL] [Abstract][Full Text] [Related]
27. Antibody persistence and booster vaccination of a fully liquid hexavalent vaccine coadministered with measles/mumps/rubella and varicella vaccines at 15-18 months of age in healthy South African infants.
Madhi SA; Koen A; Cutland C; Groome M; Santos-Lima E
Pediatr Infect Dis J; 2013 Aug; 32(8):889-97. PubMed ID: 23538523
[TBL] [Abstract][Full Text] [Related]
28. Immunization status and re-immunization of childhood acute lymphoblastic leukemia survivors.
Toret E; Yel SE; Suman M; Duzenli Kar Y; Ozdemir ZC; Dinleyici M; Bor O
Hum Vaccin Immunother; 2021 Apr; 17(4):1132-1135. PubMed ID: 32882157
[TBL] [Abstract][Full Text] [Related]
29. Immunization update.
Feldman S
Allergy Proc; 1992; 13(6):293-7. PubMed ID: 1490620
[TBL] [Abstract][Full Text] [Related]
30. Antibody persistence in children aged 6-7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection.
Díaz Ortega JL; Castaneda D; Arellano Quintanilla DM; Martínez D; Trumbo SP; Fernández de Castro J
Vaccine; 2017 May; 35(23):3116-3122. PubMed ID: 28457672
[TBL] [Abstract][Full Text] [Related]
31. [Vaccination].
Graubner UB; Liese J; Belohradsky BH
Klin Padiatr; 2001 Sep; 213 Suppl 1():A77-83. PubMed ID: 11577366
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial.
Pace D; Khatami A; McKenna J; Campbell D; Attard-Montalto S; Birks J; Voysey M; White C; Finn A; Macloed E; Faust SN; Kent AL; Heath PT; Borrow R; Snape MD; Pollard AJ
BMJ; 2015 Apr; 350():h1554. PubMed ID: 25832102
[TBL] [Abstract][Full Text] [Related]
33. Immunogenicity and safety of a DTaP-IPV//PRP-T vaccine (Pentaxim) booster during the second year of life in Thai children primed with an acellular pertussis combined vaccine.
Thisyakorn U; Pancharoen C; Chuenkitmongkol S; Ortiz E
Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):282-94. PubMed ID: 19323013
[TBL] [Abstract][Full Text] [Related]
34. Adherence and immune response to revaccination following hematopoietic stem cell transplantation at a pediatric onco-hematology reference center.
Gouveia-Alves F; Gouveia R; Ginani VC; Seber A; Kuramoto DA; Murad GFA; Spina FG; Petrilli AS; Zecchin VG; Granato C; Carlesse F; de Moraes-Pinto MI
Transpl Infect Dis; 2018 Aug; 20(4):e12903. PubMed ID: 29668078
[TBL] [Abstract][Full Text] [Related]
35. Today's vaccination policies in Italy: The National Plan for Vaccine Prevention 2017-2019 and the Law 119/2017 on the mandatory vaccinations.
Di Pietro A; Visalli G; Antonuccio GM; Facciolà A
Ann Ig; 2019; 31(2 Supple 1):54-64. PubMed ID: 30994164
[TBL] [Abstract][Full Text] [Related]
36. Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib).
Martinón-Torres F; Boisnard F; Thomas S; Sadorge C; Borrow R;
Vaccine; 2017 Jun; 35(30):3764-3772. PubMed ID: 28583305
[TBL] [Abstract][Full Text] [Related]
37. Active immunization of children with leukemia and other malignancies.
Ridgway D; Wolff LJ
Leuk Lymphoma; 1993 Feb; 9(3):177-92. PubMed ID: 8471977
[TBL] [Abstract][Full Text] [Related]
38. Measles and rubella antibody status in children after treatment for acute lymphoblastic leukemia.
Volc SM; Almeida MT; Abadi MD; Cornacchioni AL; Odone Filho V; Cristofani LM
J Pediatr (Rio J); 2006; 82(6):481-4. PubMed ID: 17003944
[TBL] [Abstract][Full Text] [Related]
39. Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa.
Vesikari T; Rivera L; Korhonen T; Ahonen A; Cheuvart B; Hezareh M; Janssens W; Mesaros N
Hum Vaccin Immunother; 2017 Jul; 13(7):1505-1515. PubMed ID: 28340322
[TBL] [Abstract][Full Text] [Related]
40. An Immune Recovery-Based Revaccination Protocol for Pediatric Hematopoietic Stem Cell Transplant Recipients: Revaccination Outcomes Following Pediatric HSCT.
Haynes AS; Curtis DJ; Campbell K; Giller RH; Quinones RR; Verneris MR; Abzug MJ
Transplant Cell Ther; 2021 Apr; 27(4):317-326. PubMed ID: 33836875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
